Stoke Therapeutics Inc buy Chardan Capital
Start price
19.02.25
/
50%
€8.95
Target price
19.02.26
€23.00
Performance (%)
86.59%
Price
22.08.25
€16.70
Summary
This prediction is currently active. With a performance of 86.59% the BUY prediction by Chardan_Capital is a big success. This prediction currently runs until 19.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 7.051% | 7.051% |
| iShares Core DAX® | -0.099% | 1.027% |
| iShares Nasdaq 100 | -1.085% | 2.134% |
| iShares Nikkei 225® | -0.835% | 8.556% |
| iShares S&P 500 | 0.099% | 2.881% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
21.01%
22.08.25
22.08.25
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€10.70
20.12.24
20.12.24
€23.06
20.12.25
20.12.25
56.07%
22.08.25
22.08.25